Abstract:Objective: Invasion and metastasis of papillary thyroid carcinoma (PTC) significantly affects prognosis and quality of life of patients. Herein, we explored the binding relationship of long noncoding RNA PVT1 as ceRNA to microRNA-30a (miR-30a), and their effect on the development of PTC through regulating insulin like growth factor 1 receptor (IGF1R). Methods: PTC and adjacent normal tissues were collected, where the qRT-PCR and western blot assay were employed to evaluate the expression levels of PVT1, miR-30a and IGF1R. The correlation between PVT1 expression and clinicopathological characteristics of PTC patients was observed. PTC cell lines with the most/least significant difference from normal thyroid cells were selected and treated with siRNA PVT1 or overexpression PVT1 plasmids, miR-30a mimics or miR-30a inhibitors. Nucleus and cytoplasm segmentation was used to identify subcellular fractionation of PVT1. The binding relationship of PVT1 to miR-30a and the targeting relationship of miR-30a to IGF1R were confirmed by using bioinformatic prediction program, dual-luciferase reporter gene assay and RNA-pull down. Cell viability, cell cycle and apoptosis, invasion and migration capacities were assessed by MTT, flow cytometry, Transwell assay and scratch test, respectively. Western blot assay was employed to examine protein expression of IGF1R, apoptosis-related factors (caspase-3, cleaved capase-3) and epithelial-mesenchymal transition (EMT)-related factors (E-cadherin, Vimentin). Results: In the PTC tissues and cells, PVT1 and IGF1R were highly expressed and miR-30a was poorly expressed. PVT1 exerted its effects on PTC mainly in the cytoplasm. The PVT1 expression was correlated with TNM staging, LNM and tumor infiltration of PTC. The competitive binding of PVT1 to miR-30a enhanced expression of IGF1R. In the in vitro experiments, BCPAP and TPC-1 cells were selected. When subjected to siRNA PVT1 or miR-30a mimics, BCPAP and TPC-1 cells exhibited inhibited proliferation, cell cycle progression, invasion, migration, EMT (increased E-cadherin and reduced Vimentin) and promoted apoptosis (reduced caspase-3 and increased cleaved capase-3), and moreover, the expression of IGF1R was reduced. Conclusion: This study provides evidence that long noncoding RNA PVT1 enhances the expression of IGF1R through competitive binding to miR-30a, whereby PVT1 facilitates the development of PTC.

PVT1 affects growth of glioma microvascular endothelial cells by negatively regulating miR-186.

PVT1 Regulates the Malignant Behaviors of Human Glioma Cells by Targeting Mir-190A-5p and Mir-488-3p.

LncRNA PVT1 influences breast cancer cells glycolysis through sponging miR-145-5p

Long Non‑coding RNA PVT1 Promotes Epithelial‑mesenchymal Transition Via the TGF‑β/Smad Pathway in Pancreatic Cancer Cells.

LncRNA-PVT1 Indicates a Poor Prognosis and Promotes Angiogenesis Via Activating the HNF1B/EMT Axis in Glioma

Lowly Expressed Lncrna PVT1 Suppresses Proliferation and Advances Apoptosis of Glioma Cells Through Up-Regulating Microrna-128-1-5p and Inhibiting PTBP1

Long noncoding RNA PVT1 promotes breast cancer proliferation and metastasis by binding miR-128-3p and UPF1

Long non-coding RNA PVT1 indicates a poor prognosis of glioma and promotes cell proliferation and invasion via target EZH2.

Long Noncoding RNA PVT1 Promotes Stemness and Temozolomide Resistance Through Mir-365/Elf4/sox2 Axis in Glioma.

PVT1 promotes proliferation and macrophage immunosuppressive polarization through STAT1 and CX3CL1 regulation in glioblastoma multiforme

Introduction of Plasmid-Mediated Exogenous Microrna to Silence PTTG1 Gene Expression and Inhibit Proliferation and Invasiveness of Glioma Cells HUANG Qing-feng, LU Yi-eheng, BAI

Effect of Long Non-Coding RNA PVT1 on Cell Proliferation and Migration in Melanoma

The Long Noncoding RNA PVT1 Functions As a Competing Endogenous RNA by Sponging Mir-186 in Gastric Cancer.

SNHG15 Affects the Growth of Glioma Microvascular Endothelial Cells by Negatively Regulating Mir-153

Long Non-Coding RNA Taurine Upregulated 1 Enhances Tumor-Induced Angiogenesis Through Inhibiting Microrna-299 in Human Glioblastoma

LncRNA PVT1 Regulates VEGFC Through Inhibiting Mir-128 in Bladder Cancer Cells

lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients

PVT1 Knockdown Inhibits Autophagy and Improves Gemcitabine Sensitivity by Regulating the MiR-143/HIF-1α/VMP1 Axis in Pancreatic Cancer

Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor

LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes

Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer